Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-06-03 | Gary J. Nabel, M.D., Ph.D. Dr. Nabel was appointed as Chief Innovation Officer of the Company and as a director on May 9, 2022. ... Gary J. Nabel, M.D., Ph.D. 68 2022 Director and Chief Innovation Officer |
| 2023-05-01 | Gary J. Nabel, M.D., Ph.D. Dr. Nabel was appointed as Chief Innovation Officer of the Company and as a director on May 9, 2022. |
| 2024-02-29 | Gary J. Nabel, M.D., Ph.D., Age 70, Director and Chief Innovation Officer since 2022. |
| 2025-03-14 | Gary J. Nabel, M.D., Ph.D. Dr. Nabel was appointed as Chief Innovation Officer of the Company and as a director on May 9, 2022. ... Dr. Nabel’s broad experience and expertise within the pharmaceutical and biotech industries, as well as his history of leadership within the National Institutes of Health, will provide the Board with valuable insights into many aspects of our business, including with respect to our science based and research and development programs. |
Data sourced from SEC filings. Last updated: 2026-02-03